HK1042307A1 - 具有刺激胰島素分泌功能的肽 - Google Patents

具有刺激胰島素分泌功能的肽

Info

Publication number
HK1042307A1
HK1042307A1 HK02103568.4A HK02103568A HK1042307A1 HK 1042307 A1 HK1042307 A1 HK 1042307A1 HK 02103568 A HK02103568 A HK 02103568A HK 1042307 A1 HK1042307 A1 HK 1042307A1
Authority
HK
Hong Kong
Prior art keywords
preptin
peptide
functionality
preptin functionality
Prior art date
Application number
HK02103568.4A
Other languages
English (en)
Chinese (zh)
Inventor
James Smith Cooper Garth
Maree Buchanan Christina
Original Assignee
Protemix Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protemix Discovery Ltd filed Critical Protemix Discovery Ltd
Publication of HK1042307A1 publication Critical patent/HK1042307A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
HK02103568.4A 1999-06-18 2002-05-11 具有刺激胰島素分泌功能的肽 HK1042307A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ33635999 1999-06-18
PCT/NZ2000/000102 WO2000078805A1 (fr) 1999-06-18 2000-06-19 Peptide ayant une fonctionnalite preptine

Publications (1)

Publication Number Publication Date
HK1042307A1 true HK1042307A1 (zh) 2002-08-09

Family

ID=19927343

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103568.4A HK1042307A1 (zh) 1999-06-18 2002-05-11 具有刺激胰島素分泌功能的肽

Country Status (7)

Country Link
EP (1) EP1185558A4 (fr)
JP (1) JP2003503019A (fr)
CN (1) CN1296384C (fr)
AU (1) AU759203B2 (fr)
CA (1) CA2375207A1 (fr)
HK (1) HK1042307A1 (fr)
WO (1) WO2000078805A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018392A1 (fr) 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine-oxydase: antagonistes et inhibiteurs
AU2003225442B2 (en) 2002-03-08 2010-02-04 Philera New Zealand Limited Preventing and/or treating cardiovascular disease and/or associated heart failure
AU2003258895A1 (en) * 2002-08-01 2004-02-23 Protemix Discovery Limited Methods of use of compounds with preptin function
US20060116318A1 (en) * 2002-08-01 2006-06-01 Jillian Cornish Preptin methods of use
EP1539129A4 (fr) 2002-08-20 2006-03-08 Protemix Corp Ltd Formes posologiques et traitements s'y rapportant
PT1778618E (pt) 2004-07-19 2014-03-04 Philera New Zealand Ltd Síntese de trietilenotetraminas
EP1871796A4 (fr) 2005-04-20 2009-01-14 Auckland Uniservices Ltd Vésiculines
WO2010086867A2 (fr) 2009-02-02 2010-08-05 Ramot At Tel Aviv University Ltd. Peptides, compositions pharmaceutiques en contenant et leurs utilisations
US8901074B2 (en) 2010-08-04 2014-12-02 Ramot At Tel-Aviv University Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3581528D1 (de) * 1984-07-13 1991-02-28 Chiron Corp Insulinaehnlicher wachstumsfaktor ii.
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
WO1989006135A1 (fr) * 1988-01-11 1989-07-13 Amylin Corporation Traitement du diabete sucre du type 2
ES2080802T3 (es) * 1989-07-10 1996-02-16 Amylin Pharmaceuticals Inc Uso de un antagonista de amilina en la preparacion de un medicamento para el tratamiento de la obesidad e hipertension intrinseca y desordenes asociados.
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions

Also Published As

Publication number Publication date
CN1355813A (zh) 2002-06-26
JP2003503019A (ja) 2003-01-28
AU5717800A (en) 2001-01-09
CN1296384C (zh) 2007-01-24
WO2000078805A1 (fr) 2000-12-28
AU759203B2 (en) 2003-04-10
CA2375207A1 (fr) 2000-12-28
EP1185558A1 (fr) 2002-03-13
EP1185558A4 (fr) 2006-02-15

Similar Documents

Publication Publication Date Title
HK1036997A1 (en) Peptides
GB0014870D0 (en) Peptides
GB0128994D0 (en) Peptides
EP1173467A4 (fr) Peptides synthetiques issus de chimiokines
GB9918156D0 (en) Synthetic peptides
GB9825854D0 (en) Peptide
GB0029777D0 (en) Peptides
EP1185558A4 (fr) Peptide ayant une fonctionnalite preptine
EP1159288A4 (fr) Peptides alpha-conotoxine
EP1147130A4 (fr) Peptides d'alpha-conotoxine
GB9812675D0 (en) Peptides
GB9904695D0 (en) Peptide
GB9908920D0 (en) Peptide
GB0001825D0 (en) Peptides
GB0120713D0 (en) Peptides
HK1045173A1 (zh) 多肽
GB9807890D0 (en) Peptides
EP1151100A4 (fr) Peptides designes tau-conotoxines
GB0007263D0 (en) Peptides
GB9917565D0 (en) Peptide
GB9907216D0 (en) Peptide
GB9918680D0 (en) Polypeptide
GB9928325D0 (en) Peptides
GB9907911D0 (en) Peptides
GB9918601D0 (en) Novel peptides

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)